Trade-off between the benefits of lithium treatment and the risk of chronic kidney disease

Nephrology

Volumn 17, Issue 8, 2012, Pages 776-779

  Adam, William R ^a   Sshweitzer, Isaac ^a   Walker, Rowan G ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; LITHIUM; PLACEBO;

BIPOLAR DISORDER; CHRONIC KIDNEY DISEASE; CREATININE CLEARANCE; DIAGNOSTIC TEST; DRUG EFFICACY; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR AFFECTIVE DISORDER; PRIORITY JOURNAL; REVIEW; SUICIDE; SUICIDE ATTEMPT;

AFFECT; ANTIMANIC AGENTS; BIPOLAR DISORDER; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; LITHIUM CARBONATE; PATIENT SELECTION; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84868118626     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2012.01641.x     Document Type: Review

References (22)

1. Mahli GS, Tanious M, Das P, Berk M,. The science and practice of lithium therapy. Aust. N. Z. J. Psychiatry 2012; 46: 192-211.
2. Cipriani A, Pretty H, Hawton K, Geddes JR,. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: A systematic review of randomized trials. Am. J. Psychiatry 2005; 162: 1805-19. (Pubitemid 41428610)
3. Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J,. Decreased risk of suicides and attempts during long-term lithium treatment: A meta-analytic review. Bipolar Disord. 2006; 8: 625-39. (Pubitemid 44567144)
4. Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM,. Long-term lithium therapy for bipolar disorder: Systematic review and meta-analysis of randomized controlled trials. Am. J. Psychiatry 2004; 161: 217-22. (Pubitemid 38419270)
5. Chadban S, Briganti EM, Kerr PG, et al,. Prevalence of kidney damage in Australian adults: The AusDiab study. J. Am. Soc. Nephrol. 2003; 14: S131-8. (Pubitemid 36750508)
6. Sterner G, Frennby B, Mansson S, Nyman U, Van Westen D, Almen T,. Determining 'true' glomerular filtration rate in healthy adults using infusion of inulin and comparing it with values obtained using other clearance techniques or prediction equations. Scand. J. Urol. Nephrol. 2008; 42: 278-85. (Pubitemid 351574390)
7. Adam WR,. Utility, or not, of estimates of glomerular filtration rate in modifying drug dosage, with particular reference to enoxaparin. Intern. Med. J. 2012; 42: 463-6.
8. Boton R, Gaviria M, Batlle DC,. Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am. J. Kidney Dis. 1987; 10: 329-45. (Pubitemid 17161686)
9. Vestergaard P, Amdisen A, Hansen HE, Schou M,. Lithium treatment and kidney function. A survey of 237 patients in long-term treatment. Acta Psychiatr. Scand. 1979; 60: 504-20. (Pubitemid 10213360)
10. Hetmar O, Povlsen UJ, Ladefoged J, Bolwig TG,. Lithium: Long-term effects on the kidney. A prospective follow-up study ten years after kidney biopsy. Br. J. Psychiatry 1991; 158: 53-8.
11. Presne C, Fakhouri F, Noel LH, et al,. Lithium-induced nephropathy: Rate of progression and prognostic factors. Kidney Int. 2003; 64: 585-92. (Pubitemid 36871930)
12. Blair G, Hurst K, McDonald S,. 'New patients commencing treatment in 2010' in The 34th Annual ANZDATA Report 2011. Australian and New Zealand Transplant Registry. [Cited 30 March 2012.] Available from URL: http://www.anzdata.org.au/vI/report-2011.html
13. Walker RG, Davies BM, Holwill BJ, Dowling JP, Kincaid-Smith PA,. Clinico-pathological study of lithium nephrotoxicity. J. Chronic Dis. 1982; 35: 685-95.
14. Markowitz GS, Radhakrishnan J, Kambham N, Valeri A, Hines WH, D'Agati VD,. Lithium nephrotoxicity: A progressive combined glomerular and tubulointerstitial nephropathy. J. Am. Soc. Nephrol. 2000; 11: 1439-48. (Pubitemid 30483460)
15. Farres MT, Ronco P, Saadoun D, et al,. Chronic lithium nephropathy: MR imaging for diagnosis. Radiology 2003; 229: 570-74. (Pubitemid 37310848)
16. Decina P, Pedicelli C, Diana G, Chiesi A, Tropeano G,. Lithium-induced tardive nephropathy: MRI contribution to the detection of pre-symptomatic renal abnormalities. Giorn. Ital. Psicopat. 2010; 16: 321-5.
17. Adam WR,. False alarms: Substantial self-limiting fluctuations in plasma creatinine in the elderly with stage 3 or 4 renal failure. Nephrology 2010; 15: 593-4.
18. Hetmar O, Brun C, Ladefoged J, Larsen S, Bolwig TG,. Long-term effects of lithium on the kidney: Functional-morphological correlations. J. Psychiatr. Res. 1989; 23: 285-97. (Pubitemid 20162903)
19. Hestbech H, Hansen HE, Amdisen A, Olsen S,. Chronic renal lesions following long-term treatment with lithium. Kidney Int. 1977; 12: 205-13. (Pubitemid 8190798)
20. Johnson GFS, Hunt GE, Duggin GD, Horvath JS, Tiller DJ,. Renal function and lithium treatment: Initial and follow-up tests in manic-depressive patients. J. Affect. Disord. 1984; 6: 249-63. (Pubitemid 14089168)
21. Juurlink DN, Mamdani MM, Kopp A, Rochon PA, Shulman KI, Redelmeier DA,. Drug-induced lithium toxicity in the elderly: A population-based study. J. Am. Geriatr. Soc. 2004; 52: 794-8. (Pubitemid 38596502)
22. Post RM, Weiss SRB,. Tolerance to the prophylactic effects of carbamazepine and related mood stabilizers in the treatment of bipolar disorders. CNS Neurosci. Ther. 2011; 17: 649-60.